alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › sub

sub

9 studies tagged sub, dated 2018-01-09 to 2025-02-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts 2025-02-01
  2. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration 2025-01-08
  3. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau 2021-12-02

Studies

9 studies carry this tag.

Date range

2018 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 4
  • ACS chemical neuroscience 1
  • Brain and behavior 1
  • CNS neuroscience & therapeutics 1
  • International journal of molecular sciences 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-02-01 Biomarkers

    Severity of cognitive impairment and race both influence plasma p-Tau 217 levels beyond race-associated differences in CSF p-Tau 181 .

  2. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-01-08 Biomarkers

    Plasma p-tau 217 and the NfL/p-tau 217 ratio are promising non-invasive biomarkers for differentiating AD from FTLD, suggesting their use as a potential alternative to traditional diagnostic methods.

  3. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021-12-02 Biomarkers

    These results support plasma p-tau 181 for the detection of AD dementia and the use of blood-based biomarkers for optimal disease detection.

  4. RETRACTED: Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ1-42-Induced Alzheimer's Disease

    ⚠ Retracted — do not rely on it alzhub usefulness score 16 out of 100. International journal of molecular sciences 2021-09-03 Biomarkers

    The current study was undertaken to unveil the protective effects of Luteolin, a natural flavonoid, against amyloid-beta (Aβ 1 - 42 )-induced neuroinflammation, amyloidogenesis, and synaptic dysfunction in mice.

  5. Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. ACS chemical neuroscience 2021-04-07 Biomarkers

    Beta-amyloid (Aβ 1-42 ) triggers the phosphorylation of tau protein in Alzheimer's disease (AD), but the relationship between phosphorylated tau (p-tau) and Aβ 1-42 in the blood is not elucidated.

  6. Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of neurology, neurosurgery, and psychiatry 2020-07-01 Biomarkers

    The assessment of serum NfL and p-Tau 181 may provide a comprehensive view of FTLD, aiding in the differential diagnosis, in staging disease severity and in defining survival probability.

  7. Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. CNS neuroscience & therapeutics 2018-02-17 Biomarkers

    These results indicate that FS (p-tau231 and MMSE) has a strong potential to provide an early distinction between AD and VaD.

  8. Neurodegenerative disease biomarkers Aβ1-40, Aβ1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Brain and behavior 2018-01-13 Biomarkers

    Overall, these results support the vervet as a non-human primate model of amyloid-related neurodegeneration, such as Alzheimer's disease and cerebral amyloid angiopathy, and highlight Aβ 1-40 and p-tau 181 as potentially valuable biomarkers of these processes.

  9. Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40

    ✓ Peer-reviewed alzhub usefulness score 49 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2018-01-09 Biomarkers

    Novel and established cerebrospinal fluid markers perform with at least fair accuracy in the discrimination between ADD and FTD.

All topic tags with their study counts